Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
inegy tafla 10/40 mg
n.v. organon* - simvastatinum inn; ezetimibum inn - tafla - 10/40 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
inegy tafla 10/80 mg
n.v. organon* - simvastatinum inn; ezetimibum inn - tafla - 10/80 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
maxalt smelt frostþurrkuð tafla 10 mg
n.v. organon* - rizatriptanum benzóat - frostþurrkuð tafla - 10 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
simvastatin actavis filmuhúðuð tafla 20 mg
actavis group ptc ehf. - simvastatinum inn - filmuhúðuð tafla - 20 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
simvastatin actavis filmuhúðuð tafla 40 mg
actavis group ptc ehf. - simvastatinum inn - filmuhúðuð tafla - 40 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
simvastatín alvogen (simvastatín portfarma) filmuhúðuð tafla 20 mg
alvogen ehf. - simvastatinum inn - filmuhúðuð tafla - 20 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
simvastatín alvogen (simvastatín portfarma) filmuhúðuð tafla 40 mg
alvogen ehf. - simvastatinum inn - filmuhúðuð tafla - 40 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
simvastatin bluefish filmuhúðuð tafla 10 mg
bluefish pharmaceuticals ab - simvastatinum inn - filmuhúðuð tafla - 10 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
simvastatin bluefish filmuhúðuð tafla 20 mg
bluefish pharmaceuticals ab - simvastatinum inn - filmuhúðuð tafla - 20 mg
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
ebglyss
almirall, s.a. - lebrikizumab - dermatitis, atópísk - aðrar húðsjúkdómar - ebglyss is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older with a body weight of at least 40 kg who are candidates for systemic therapy.